The effect of weight loss on inflammation in obese women with polycystic ovary syndrome

Endokrynol Pol. 2008 Jan-Feb;59(1):13-7.

Abstract

Introduction: The aim of the present study was to evaluate the effect of modest weight reduction on serum concentrations of tumour necrosis factor alpha (TNF-alpha), TNF soluble receptors (sTNFRs) and interleukin-6 (IL-6) in obese women with polycystic ovary syndrome (PCOS).

Material and methods: The study group consisted of 15 obese women with PCOS (mean age 28.5 +/- 7.7 years). Serum concentrations of TNF-alpha, sTNFRs and IL-6, insulin, FSH, LH, DHEAS, androstendione, total and free testosterone, cortisol, 17OH-progesterone, oestradiol and sex hormone binding globulin (SHBG), glucose, total cholesterol, HDL cholesterol and triglycerides were measured before treatment and after 10% weight loss. All patients were advised to follow a 1000-1200 kcal diet with a limited intake of simple carbohydrate and animal fats and to exercise regularly (30 min, 3 times a week). Body composition was measured by bioimpedance. Serum concentrations of TNF-alpha, sTNFRs and IL-6 were determined by enzyme linked immunosorbent assay (ELISA). Plasma insulin, FSH, LH, DHEAS, androstendione, total and free testosterone, cortisol, 17OH-progesterone, oestradiol and SHBG were measured by a commercial RIA. Blood glucose, total cholesterol, HDL cholesterol and triglycerides were measured by an enzymatic procedure.

Results: We observed no differences in serum concentrations of TNF-alpha, sTNFRs or IL-6 after treatment.

Conclusions: It seems that more than a modest weight reduction is necessary to obtain a decrease in serum concentrations of proinflammatory cytokines and an improvement in ovarian function in obese women with polycystic ovary syndrome.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Androstenedione / blood
  • Blood Glucose / analysis
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Dehydroepiandrosterone Sulfate / blood
  • Diet, Reducing
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Hydrocortisone / blood
  • Inflammation / blood*
  • Inflammation / complications
  • Insulin / blood
  • Interleukin-6 / blood
  • Luteinizing Hormone / blood
  • Middle Aged
  • Obesity / blood*
  • Obesity / complications
  • Obesity / diet therapy
  • Poland
  • Polycystic Ovary Syndrome / blood*
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / diet therapy*
  • Receptors, Tumor Necrosis Factor, Type I / blood
  • Receptors, Tumor Necrosis Factor, Type II / blood
  • Sex Hormone-Binding Globulin / metabolism
  • Statistics, Nonparametric
  • Testosterone / blood
  • Triglycerides / blood
  • Tumor Necrosis Factor-alpha / blood
  • Weight Loss*

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Insulin
  • Interleukin-6
  • Receptors, Tumor Necrosis Factor, Type I
  • Receptors, Tumor Necrosis Factor, Type II
  • Sex Hormone-Binding Globulin
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Testosterone
  • Androstenedione
  • Estradiol
  • Dehydroepiandrosterone Sulfate
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Cholesterol
  • Hydrocortisone